Rescue of cognitive deficits in APP/PS1 mice by accelerating the aggregation of ß-amyloid peptide


Zhang, J., Lai, Y., Mi, P., et al.

Alzheimer's Research and Therapy 2019, vol:11, 106 doi: 10.1186/s13195-019-0560-6


Brain amyloid deposition is one of the main pathological characteristics of Alzheimer’s disease (AD). Soluble oligomers formed during the process that causes β-amyloid (Aβ) to aggregate into plaques are considered to have major neurotoxicity. Currently, drug development for the treatment of Alzheimer’s disease has encountered serious difficulties. Our newly proposed solution is to accelerate the aggregation of Aβ to reduce the amount of cytotoxic Aβ oligomers in brain tissue. This strategy differs from the existing strategy of reducing the total Aβ content and the number of amyloid plaques.

View Publication

Topics: Neurodegenerative diseases, Monolith – MicroScale Thermophoresis, MST,  Publications



Previous Article
Prolyl oligopeptidase enhances alpha-syn dimerization
Prolyl oligopeptidase enhances alpha-syn dimerization

Up next
Structural basis of small molecule targetability of monomeric tau protein
Structural basis of small molecule targetability of monomeric tau protein


Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!